Annual Report 2025

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2025 99 The United Laboratories International Holdings Limited Annual Report 2025 13. DIRECTORS’ AND CHIEF EXECUTIVE’S EMOLUMENTS Directors’ and chief executive’s remuneration for the year, disclosed pursuant to the applicable Listing Rules and Hong Kong Companies Ordinance, is as follows: 2025 (a) Executive directors Tsoi Leung Choy Fang Zou Zhu Hoi Shan Wing Hon Siu Chit Yu Ping Xian Hong Su Yan Total RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 (Note) Fees – – – – – – – Other emoluments – – – – – – – Salaries and other benefits 4,255 4,122 2,825 1,828 1,828 1,828 16,686 Bonus – 196 – 720 720 720 2,356 Contributions to retirement benefit schemes 17 17 17 – – – 51 Share-based compensation expenses 1,009 703 471 328 328 328 3,167 Sub-total 5,281 5,038 3,313 2,876 2,876 2,876 22,260 The executive directors’ emoluments shown above were for their services in connection with the management of the affairs of the Company and the Group. The directors’ share-based compensation expenses are disclosed in Note 32. (b) Independent non-executive directors Chong Song Fu Peng Oon Ming Qiushi Total RMB’000 RMB’000 RMB’000 RMB’000 Fees 238 238 238 714 The independent non-executive directors’ emoluments shown above were for their services as directors of the Company. Total 22,974